• Je něco špatně v tomto záznamu ?

Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations

Z Kleibl, O Havranek, J Novotny, P Kleiblova, P Soucek, P Pohlreich

. 2008 ; 112 (1) : 159-64.

Jazyk angličtina Země Nizozemsko

Typ dokumentu srovnávací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc11004771
E-zdroje Online

NLK ProQuest Central od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2005-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do Před 1 rokem
Family Health Database (ProQuest) od 1997-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 1997-01-01 do Před 1 rokem

The CHEK2 gene mutations I157T (c.470T>C) and IVS2+1G>A affecting the forkhead-associated domain (FHA) have been shown to increase the risk of breast cancer development in several populations. We analyzed the CHEK2 gene segment coding for FHA domain in 673 unselected breast cancer patients and 683 controls from the Czech Republic using the denaturant high-performance liquid chromatography. The found frequency of predominant FHA alteration I157T did not differ between breast cancer patients (19/673; 2.82%) and controls (17/683; 2.49%; P=0.71). Besides this mutation we characterized another nine alterations-six located within FHA coding sequence and three occurring in introns 1 or 2). Eight variants occurred once each in patients with breast cancer and two were present in controls. Three alterations found in breast cancer patients were novel missense variants (Y159H, T172A, and L174F) affecting highly conservative residues in FHA domain. Despite the lack of association of I157T mutation with breast cancer development in our population we deduced that the FHA domain is the subject of rare population-specific alterations that might modify risk of various cancers.

000      
03385naa 2200517 a 4500
001      
bmc11004771
003      
CZ-PrNML
005      
20121127121515.0
008      
110309s2008 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Kleibl, Zdeněk, $d 1969- $7 jo2003183974
245    10
$a Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations / $c Z Kleibl, O Havranek, J Novotny, P Kleiblova, P Soucek, P Pohlreich
314    __
$a Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. zdekleje@lf1.cuni.cz
520    9_
$a The CHEK2 gene mutations I157T (c.470T>C) and IVS2+1G>A affecting the forkhead-associated domain (FHA) have been shown to increase the risk of breast cancer development in several populations. We analyzed the CHEK2 gene segment coding for FHA domain in 673 unselected breast cancer patients and 683 controls from the Czech Republic using the denaturant high-performance liquid chromatography. The found frequency of predominant FHA alteration I157T did not differ between breast cancer patients (19/673; 2.82%) and controls (17/683; 2.49%; P=0.71). Besides this mutation we characterized another nine alterations-six located within FHA coding sequence and three occurring in introns 1 or 2). Eight variants occurred once each in patients with breast cancer and two were present in controls. Three alterations found in breast cancer patients were novel missense variants (Y159H, T172A, and L174F) affecting highly conservative residues in FHA domain. Despite the lack of association of I157T mutation with breast cancer development in our population we deduced that the FHA domain is the subject of rare population-specific alterations that might modify risk of various cancers.
650    _2
$a nádory prsu $x genetika $x patologie $7 D001943
650    _2
$a duktální karcinom prsu $x epidemiologie $x genetika $x patologie $7 D018270
650    _2
$a intraduktální neinfiltrující karcinom $x epidemiologie $x genetika $x patologie $7 D002285
650    _2
$a lobulární karcinom $x genetika $x patologie $7 D018275
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a missense mutace $x genetika $7 D020125
650    _2
$a prognóza $7 D011379
650    _2
$a terciární struktura proteinů $7 D017434
650    _2
$a protein-serin-threoninkinasy $x genetika $7 D017346
650    _2
$a financování organizované $7 D005381
651    _2
$a Česká republika $7 D018153
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Havránek, Ondřej $7 xx0128548
700    1_
$a Novotný, Jan, $d 1971- $7 jo2003184375
700    1_
$a Kleiblová, Petra $7 xx0125463
700    1_
$a Souček, Pavel $7 xx0060511
700    1_
$a Pohlreich, Petr, $d 1947-2015 $7 jn20000710479
773    0_
$t Breast Cancer Research & Treatment $w MED00009361 $g Roč. 112, č. 1 (2008), s. 159-64 $x 0167-6806
910    __
$a ABA008 $b x $y 1
990    __
$a 20110414093501 $b ABA008
991    __
$a 20121127121542 $b ABA008
999    __
$a ok $b bmc $g 832149 $s 696809
BAS    __
$a 3
BMC    __
$a 2008 $b 112 $c 1 $d 159-64 $i 0167-6806 $m Breast cancer research and treatment $n Breast Cancer Res Treat $x MED00009361
LZP    __
$a 2011-4B/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...